RBOT (Vicarious Surgical) 3-Year EBITDA Growth Rate: 0.00% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Vicarious Surgical 3-Year EBITDA Growth Rate?

Vicarious Surgical RBOT -10.71% 3-Year EBITDA Growth Rate is 0.00% as of Mar. 2026. The stock has 2 warning signs investors should review. Among 688 Medical Devices & Instruments companies, Vicarious Surgical ranks worse than 145348.69% on this metric.

Vicarious Surgical's EBITDA per Share for the three months ended in Mar. 2026 was $-1.03.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 6 years, the highest 3-Year average EBITDA Per Share Growth Rate of Vicarious Surgical was -0.50% per year. The lowest was -64.10% per year. And the median was -32.30% per year.

Vicarious Surgical  (OTCPK:RBOT) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Vicarious Surgical 3-Year EBITDA Growth Rate Related Terms

RBOT vs SSKN, VTAK, ODYY: 3-Year EBITDA Growth Rate Comparison

For the Medical Devices subindustry, Vicarious Surgical's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vicarious Surgical 3-Year EBITDA Growth Rate vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vicarious Surgical's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Vicarious Surgical's 3-Year EBITDA Growth Rate falls into.


Vicarious Surgical 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 3-Year EBITDA Growth Rate of 0.00% mean?
Vicarious Surgical (RBOT) has a 3-Year EBITDA Growth Rate of 0.00% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Vicarious Surgical and its competitors. According to the industry distribution chart, Vicarious Surgical ranks #999999 out of 688 companies in the Medical Devices & Instruments industry.
Is Vicarious Surgical's 3-Year EBITDA Growth Rate too high?
Vicarious Surgical's current 3-Year EBITDA Growth Rate is 0.00%. Based on the distribution chart, Vicarious Surgical ranks #999999 out of 688 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Vicarious Surgical's 3-Year EBITDA Growth Rate compare to SSKN and VTAK?
According to the Medical Devices & Instruments industry distribution chart, Vicarious Surgical ranks #999999 out of 688 companies for 3-Year EBITDA Growth Rate. This places Vicarious Surgical in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 7.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Medical Devices & Instruments company?
The median 3-Year EBITDA Growth Rate among Medical Devices & Instruments companies is 7.90, based on 688 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Vicarious Surgical and its competitors. For the Medical Devices & Instruments industry, the median 3-Year EBITDA Growth Rate is 7.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vicarious Surgical's current 3-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vicarious Surgical stock overvalued right now?
Vicarious Surgical (RBOT) has a current 3-Year EBITDA Growth Rate of 0.00%. The current 3-Year EBITDA Growth Rate is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Vicarious Surgical (RBOT), the current 3-Year EBITDA Growth Rate is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vicarious Surgical Business Description

Address 78 Fourth Avenue, Waltham, MA, USA, 02451
Vicarious Surgical Inc is combining miniaturized robotics, computer science, sensing and 3D visualization to build a new category of intelligent and affordable single-port surgical robots that virtually transport surgeons inside the patient to perform minimally invasive surgery. Its single-port surgical robot, called the Vicarious Surgical System is being developed to provide attractive advantages to hospitals and ambulatory surgical centers, or ASCs, which it believes will drive rapid and widespread adoption. The company operates as one operating segment.